Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0068 | 0.9 |